Choice Sets for Advance Directives
Public ClinicalTrials.gov record NCT02209038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial of Expanded Choice Sets to Increase Completion of Advance Directives
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
There is a large gap between the care seriously ill patients want and the care they receive. Advance directives (ADs) offer an opportunity for patients to express specific end-of-life preferences to avoid unwanted care. As promising as ADs may be for improving the quality of care near the end of life, rates of AD completion remain low and previous efforts to encourage their completion have had limited success. Principles of behavioral economics, such as the effects of defaults and other framing effects, may offer a novel approach to bridge the gap in end-of-life care. The goal of this study is to test whether the framing effect of expanding choice sets can increase the completion of and specification of choices within advance directives.
Study identification
- NCT ID
- NCT02209038
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Interventions
- Expanded AD Choice Behavioral
- Expanded Life-sustaining Therapy Choice Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2014
- Primary completion
- Jun 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- Jan 6, 2016
2014 – 2015
United States locations
- U.S. sites
- 15
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lourdes-Camden | Camden | New Jersey | 08103 | — |
| Market Street DaVita | Philadelphia | Pennsylvania | 19104 | — |
| Philadelphia 42nd Street DaVita | Philadelphia | Pennsylvania | 19104 | — |
| Philadelphia PMC-Lombard DaVita | Philadelphia | Pennsylvania | 19104 | — |
| University City DaVita | Philadelphia | Pennsylvania | 19104 | — |
| Franklin DaVita | Philadelphia | Pennsylvania | 19106 | — |
| PDI Walnut Tower DaVita | Philadelphia | Pennsylvania | 19107 | — |
| Callowhill DaVita | Philadelphia | Pennsylvania | 19123 | — |
| City Line DaVita | Philadelphia | Pennsylvania | 19131 | — |
| South Broad Street | Philadelphia | Pennsylvania | 19146 | — |
| Cottman DaVita | Philadelphia | Pennsylvania | 19149 | — |
| South Philadelphia DaVita | Philadelphia | Pennsylvania | — | — |
| Radnor DaVita | Radnor | Pennsylvania | 19087 | — |
| Abington DaVita | Willow Grove | Pennsylvania | 19090 | — |
| Willow Grove DaVita | Willow Grove | Pennsylvania | 19090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02209038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2016 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02209038 live on ClinicalTrials.gov.